Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
IKARIAN CAPITAL LLC | 02-14-2024 | 12-31-2023 | 136 | 1,067,984,222 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
ULTRAGENYX PHARMACEUTICAL IN | COM | Liquidated | $0 | 0 | 0.00 | 0.00 | 53,287 | 43.80 | 12-31-2023 |
CYMABAY THERAPEUTICS INC | COM | Liquidated | $0 | 0 | 0.00 | 107,346 | +Inf | 12-31-2023 | |
LONGBOARD PHARMACEUTICALS IN | COM | 103 | $5,906,156 | 979,462 | 0.00 | 0.00 | 465,361 | 90.52 | 12-31-2023 |
IDEAYA BIOSCIENCES INC | COM | Liquidated | $0 | 0 | 0.00 | 0.00 | -273,944 | -55.81 | 12-31-2023 |